A Study on the Safety and Benefits of Waj (Sweet Flag) in Patients with Hypothyroidism

Clinical evaluation of Waj ( ACcorus calamus)in the management of subclinical and primary hypothyroidism-a single arm clinical study - Nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/101531

Enrollment

Registered

2026-01-19

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E038- Other specified hypothyroidism

Interventions

Intervention1: powder of acorus calamus(waj turki): powder of acorus calamus(waj turki) 1 gram BD for 3 months after meals Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient diagnosed with primary and subclinical hypothyroidism TSH upto 5 to 10. 2.willing to discontinue hormonal therapy 3.Ability to provide written informed consent

Exclusion criteria

Exclusion criteria: 1.patient with clinically significant renal,hepatic,endocrine(including diabetes) cardiac,pulmonary,pancreatic ,neurogenic and hepatic disorders 2.Women with pregnancy and lactation 3.Patient unwilling to sign the consent form 4.Patients with TSH greater than 10

Design outcomes

Primary

Measure	Time frame
Decrease in zulewski clinical score from 5-8Timepoint: 3 months follow up with every 15 days	—

Secondary

Measure	Time frame
Decrease in TSH levelsTimepoint: 3 months follow up with every 15 days	—

Countries

India

Contacts

Public ContactDr ARSHIYA FIRDOSE

Government nizamia tibbi college and hospital

dr.n.narasimha@gmail.com9866985269

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026